Year |
Citation |
Score |
2007 |
Bullok KE, Maxwell D, Kesarwala AH, Gammon S, Prior JL, Snow M, Stanley S, Piwnica-Worms D. Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry. 46: 4055-65. PMID 17348687 DOI: 10.1021/Bi061959N |
0.557 |
|
2006 |
Bullok KE, Gammon ST, Violini S, Prantner AM, Villalobos VM, Sharma V, Piwnica-Worms D. Permeation peptide conjugates for in vivo molecular imaging applications. Molecular Imaging. 5: 1-15. PMID 16779965 DOI: 10.2310/7290.2006.00001 |
0.575 |
|
2006 |
Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Investigative Ophthalmology & Visual Science. 47: 2589-95. PMID 16723475 DOI: 10.1167/Iovs.05-1470 |
0.576 |
|
2006 |
Hotchkiss RS, McConnell KW, Bullok K, Davis CG, Chang KC, Schwulst SJ, Dunne JC, Dietz GP, Bähr M, McDunn JE, Karl IE, Wagner TH, Cobb JP, Coopersmith CM, Piwnica-Worms D. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. Journal of Immunology (Baltimore, Md. : 1950). 176: 5471-7. PMID 16622015 DOI: 10.4049/Jimmunol.176.9.5471 |
0.66 |
|
2005 |
Bullok K, Piwnica-Worms D. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Journal of Medicinal Chemistry. 48: 5404-7. PMID 16107137 DOI: 10.1021/Jm050008P |
0.722 |
|
2002 |
Bullok KE, Dyszlewski M, Prior JL, Pica CM, Sharma V, Piwnica-Worms D. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjugate Chemistry. 13: 1226-37. PMID 12440857 DOI: 10.1021/Bc025573A |
0.65 |
|
Show low-probability matches. |